Skip to main content
Woman with arms outstretched looking at a mountainous landscape)


Driven by Our Promise

A line of people going to a CSL Behring Booth at a convention

Congress Materials

  • ERS 2022 | 4–6 Sep 2022 | View Materials
  • ERS 2021 | 5–8 Sep 2021 | View Materials 

Meet Us at an Event

ATS 2023 19-24 May 2023 Washington D.C., US Details
ERS 2023 9–13 Sep 2023 Milan, Italy Details

Faculty Interviews – ERS 2022

What is OSIC – the Open Source Imaging Consortium – about?

Elizabeth Estes - USA

The importance of data repositories and potential future techniques for diagnosis and management of interstitial lung disease

Duration: 00:02:34

Are there simple measures that could be used to help reduce diagnostic delay in interstitial lung disease (ILD)?

Dr. Marlies Wijsenbeek - Netherlands

Dr. Wijsenbeek shares key clinical insights of managing patients with interstitial lung disease

Duration: 00:01:17

Gold standard endpoint for Alpha 1 Antitrypsin Deficiency

Dr. Charlie Strange and Professor Gerry McElvaney - USA and Ireland

Importance of CT lung density as a preferential primary endpoint for Alpha 1 Antitrypsin Deficiency

Duration: 00:00:40

The role of patient organisations in rare lung diseases

Professor Daiana Stolz - Germany

The importance of involving patients and patient organisations in planning research and therapeutic decision making

Duration: 00:01:47

Our commitment to respiratory medicine

Professor Tobias Welte - Germany

Professor Tobias Welte highlights CSL Behring’s long-term commitment to respiratory medicine

Duration: 00:01:03 

Diagnosing Alpha 1 Antitrypsin Deficiency

Dr. Charlie Strange - USA

Dr. Strange discusses the importance of accurate and expedited diagnosis

Duration: 00:00:25

Pulmonary rehab for Alpha 1 patients

Dr. Rembert Koczulla - Germany

Dr. Koczulla explains what pulmonary rehabilitation can do for Alpha 1 Antitrypsin Deficiency patients

Duration: 00:01:32

Self-administration in HAE

Dr. Andrea Zanichelli - Italy

Dr. Zanichelli shares his experience with self-administration of a plasma-derived therapy

Duration: 00:00:59


  • ERS, European Respiratory Society

April 2023